CHAR vs NOEM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 22, 2026

CHAR

50.3
AI Score
VS
CHAR Wins

NOEM

49.8
AI Score

Investment Advisor Scores

CHAR

50score
Recommendation
HOLD

NOEM

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CHAR NOEM Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% 0.0% Tie
Earnings Growth -27.0% -21.8% NOEM
Tradestie Score 50.3/100 49.8/100 CHAR
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CHAR 1M: +0.7% · 3M: +1.5% NOEM 1M: +2.3% · 3M: +3.1%

Current Technical Phase

CHAR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 61

RSI (14): 61.4 · Price: $10.46

NOEM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.4 · Price: $10.69

Fundamentals Snapshot

Metric CHAR NOEM
Market Cap
Forward P/E 0.0 0.0
Trailing P/E 43.8 71.2
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin
Operating Margin 0.0% 0.0%
EPS 0.25 0.15
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CHAR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.